BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37451413)

  • 21. Concurrent primaries of vaginal clear cell adenocarcinoma and endometrial adenocarcinoma in a 39-year old woman with in utero diethylstilbestrol exposure.
    Keller C; Nanda R; Shannon RL; Amit A; Kaplan AL
    Int J Gynecol Cancer; 2001; 11(3):247-50. PubMed ID: 11437935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects in the human of diethylstilbestrol (DES) use during pregnancy.
    Herbst AL
    Princess Takamatsu Symp; 1987; 18():67-75. PubMed ID: 3506546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
    Edelman DA
    Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain.
    Lin LM; Sciubba DM; Gallia GL; Sosnowski J; Weingart JD
    Gynecol Oncol; 2007 Apr; 105(1):273-6. PubMed ID: 17292458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic.
    Piver MS; Lele SB; Baker TR; Sandecki A
    Cancer Detect Prev; 1988; 11(3-6):197-202. PubMed ID: 3390844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol.
    Horwitz RI; Viscoli CM; Merino M; Brennan TA; Flannery JT; Robboy SJ
    J Clin Epidemiol; 1988; 41(6):593-7. PubMed ID: 3385459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Findings in female offspring of women exposed in utero to diethylstilbestrol.
    Kaufman RH; Adam E
    Obstet Gynecol; 2002 Feb; 99(2):197-200. PubMed ID: 11814496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
    Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
    Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero.
    Laronda MM; Unno K; Butler LM; Kurita T
    Differentiation; 2012 Oct; 84(3):252-60. PubMed ID: 22682699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The current status of the DES-exposed population.
    Herbst AL
    Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
    Troisi R; Hatch EE; Palmer JR; Titus L; Robboy SJ; Strohsnitter WC; Herbst AL; Adam E; Hyer M; Hoover RN
    Am J Obstet Gynecol; 2016 Sep; 215(3):322.e1-8. PubMed ID: 26979629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females.
    Herbst AL; Scully RE; Robboy SJ
    J Reprod Med; 1975 Jul; 15(1):5-11. PubMed ID: 1151941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Six cases of women with diethylstilbestrol in utero demonstrating long-term manifestations and current evaluation guidelines.
    Tedeschi CA; Rubin M; Krumholz BA
    J Low Genit Tract Dis; 2005 Jan; 9(1):11-8. PubMed ID: 15870516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diethylstilbestrol and clear cell vaginal carcinoma. Reappraisal of the epidemiologic evidence.
    McFarlane MJ; Feinstein AR; Horwitz RI
    Am J Med; 1986 Nov; 81(5):855-63. PubMed ID: 3776990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
    Blythe JG; Michael H; Hodel KA
    J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma.
    Hall WB; Detterbeck FC; Livasy CA; Fowler WC
    Gynecol Oncol; 2004 Jun; 93(3):708-10. PubMed ID: 15196869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
    Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
    Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol.
    Herbst AL; Anderson D
    Semin Surg Oncol; 1990; 6(6):343-6. PubMed ID: 2263810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States).
    Hatch EE; Herbst AL; Hoover RN; Noller KL; Adam E; Kaufman RH; Palmer JR; Titus-Ernstoff L; Hyer M; Hartge P; Robboy SJ
    Cancer Causes Control; 2001 Nov; 12(9):837-45. PubMed ID: 11714112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [DES Daughter--expertise remains necessary].
    Verheijen RH; Verloop J; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2013; 157(52):A6809. PubMed ID: 24382040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.